A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Leaders of the treatment ’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
Source: NYT Health - Category: Consumer Health News Authors: Pam Belluck Tags: Clinical Trials Amyotrophic Lateral Sclerosis Drugs (Pharmaceuticals) Amylyx Pharmaceuticals Inc Food and Drug Administration Cohen, Joshua B Klee, Justin United States your-feed-healthcare Source Type: news